Solubility of disulfide-bonded proteins in the cytoplasm of Escherichia coli and its "oxidizing" mutant

World Journal of Gastroenterology

Volumn 11, Issue 7, 2005, Pages 1077-1082

  Xiong, Sheng ^a   Wang, Yi Fei ^a   Ren, Xiang Rong ^b   Li, Bing ^a   Zhang, Mei Ying ^a   Luo, Yong ^a   Zhang, Ling ^a   Xie, Qiu Ling ^a   Su, Kuan Yuan ^b  

^a JINAN UNIVERSITY   (China)

^b Department of Immuno Biochemistry   (China)

Author keywords

Affinity constant; bFGF; Disulfide bond; Escherichia coli; HBsAg; Protein folding; Recombinant protein expression; Reductase deficient; Single chain Fv; Solubility

Indexed keywords

FIBROBLAST GROWTH FACTOR; HEPATITIS B SURFACE ANTIBODY;

AFFINITY CHROMATOGRAPHY; ARTICLE; BACTERIAL STRAIN; BINDING AFFINITY; CONTROLLED STUDY; CULTURE MEDIUM; DISULFIDE BOND; ESCHERICHIA COLI; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN FOLDING; PROTEIN PURIFICATION; PROTEIN TARGETING; SOLUBILITY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 14844334893     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i7.1077     Document Type: Article

References (37)

1. Hua Q, Yang C, Oshima T, Mori H, Shimizu K. Analysis of gene expression in Escherichia coli in response to changes of growth-limiting nutrient in chemostat cultures. Appl Environ Microbiol 2004; 70: 2354-2366
2. Verma R, Boleti E, George AJ. Antibody engineering: Comparison of bacterial, yeast, insect and mammalian expression systems. J Immunol Methods 1998; 216: 165-181
3. Baneyx F. Recombinant protein expression in Escherichia coli. Curr Opin Biotechnol 1999; 10: 411-421
4. Choi GH, Lee DH, Min WK, Cho YJ, Kweon DH, Son DH, Park K, Seo JH. Cloning, expression, and characterization of single-chain variable fragment antibody against mycotoxin deoxynivalenol in recombinant Escherichia coli. Protein Expr Purif 2004; 35: 84-92
5. Machida S, Yu Y, Singh SP, Kim JD, Hayashi K, Kawata Y. Overproduction of beta-glucosidase in active form by an Escherichia coli system coexpressing the chaperonin GroEL/ES. FEMS Microbiol Lett 1998; 159: 41-46
6. Mao YF, Yan J. Construction of prokaryotic expression system of ureB gene from a clinical Helicobacter pylori strain and identification of the recombinant protein immunity. World J Gastroenterol 2004; 10: 977-984
7. http://www.merckbiosciences.com/docs/NDIS/TB330000.pdf
8. Derman AI, Prinz WA, Belin D, Beckwith J. Mutations that allow disulfide bond formation in the cytoplasm of Escherichia coli. Science 1993; 262: 1744-1747
9. Shin EY, Woo KN, Lee CS, Koo SH, Kim YG, Kim WJ, Bae CD, Chang SI, Kim EG. Basic fibroblast growth factor stimulates activation of Rac1 through a p85 betaPIX phosphorylation-dependent pathway. J Biol Chem 2004; 279: 1994-2004
10. Fox GM, Schiffer SG, Rohde MF, Tsai LB, Banks AR, Arakawa T. Production, biological activity, and structure of recombinant basic fibroblast growth factor and an analog with cysteine replaced by serine. J Biol Chem 1988; 263: 18452-18458
11. Rinas U, Tsai LB, Lyons D, Fox GM, Stearns G, Fieschko J, Fenton D, Bailey JE. Cysteine to serine substitutions in basic fibroblast growth factor: Effect on inclusion body formation and proteolytic susceptibility during in vitro refolding. Biotechnology 1992; 10: 435-440
12. McCafferty J, Glover DR. Engineering therapeutic proteins. Curr Opin Struct Biol 2000; 10: 417-420
13. Xiong S, Ren XR, Tang YH, Su KY, Yu ZY, Luo Y, Wang YF, Li JX. Expression of a human single-chain Fv antibody against HBsAg in Pichia pastoris. Shengwu Gongcheng Xuebao 2003; 19: 19-23
14. Agashe VR, Guha S, Chang HC, Genevaux P, Hayer-Hartl M, Stemp M, Georgopoulos C, Hartl FU, Barral JM. Function of trigger factor and Dnak in multidomain protein folding: Increase in yield at the expense of folding speed. Cell 2004; 117: 199-209
15. Xiong S, Lin J, Hong A, Liu JS, Zhang L, Li ZY, Yao RH. Construction and application of a pET3c derivative. Yaowu Shengwu Jishu 2001; 8: 4-7
16. Sheng Z, Chang SB, Chirico WJ. Expression and purification of a biologically active basic fibroblast growth factor fusion protein. Protein Expr Purif 2003; 27: 267-271
17. Garke G, Deckwer WD, Anspach FB. Preparative two-step purification of recombinant human basic fibroblast growth factor from high-cell-density cultivation of Escherichia coli. J Chromatogr B Biomed Sci Appl 2000; 737: 25-38
18. Knoerzer W, Binder HP, Schneider K, Gruss P, McCarthy JE, Risau W. Expression of synthetic genes encoding bovine and human basic fibroblast growth factors (bFGFs) in Escherichia coli. Gene 1989; 75: 21-30
19. Kajio T, Kawahara K, Kato K. Quantitative colorimetric assay for basic fibroblast growth factor using bovine endothelial cells and heparin. J Pharmacol Toxicol Methods 1992; 28: 9-14
20. Tsumoto K, Shinoki K, Kondo H, Uchikawa M, Juji T, Kumagai I. Highly efficient recovery of functional single-chain Fv fragments from inclusion bodies overexpressed in Escherichia coli by controlled introduction of oxidizing reagent-application to a human single-chain Fv fragment. J Immunol Methods 1998; 219: 119-129
21. Sanchez L, Ayala M, Freyre F, Pedroso I, Bell H, Falcon V, Gavilondo JV. High cytoplasmic expression in E. coli, purification, and in vitro refolding of a single chain Fv antibody fragment against the hepatitis B surface antigen. J Biotechnol 1999; 72: 13-20
22. Umetsu M, Tsumoto K, Hara M, Ashish K, Goda S, Adschiri T, Kumagai I. How additives influence the refolding of immunoglobulin-folded proteins in a stepwise dialysis system. Spectroscopic evidence for highly efficient refolding of a single-chain Fv fragment. J Biol Chem 2003; 278: 8979-8987
23. Beatty JD, Beatty BG, Vlahos WG. Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods 1987; 100: 173-179
24. Martineau P, Betton JM. In vitro folding and thermodynamic stability of an antibody fragment selected in vivo for high expression levels in Escherichia coli cytoplasm. J Mol Biol 1999; 292: 921-929
25. Prinz WA, Aslund F, Holmgren A, Beckwith J. The role of the thioredoxin and glutaredoxin pathways in reducing protein disulfide bonds in the Escherichia coli cytoplasm. J Biol Chem 1997; 272: 15661-15667
26. Bessette PH, Aslund F, Beckwith J, Georgiou G. Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc Natl Acad Sci USA 1999; 96 13703-13708
27. Xiong S, Wang YF, Qian CW, Luo Y, Chen WY, Rao GR, Su KY, Yu ZY. Isoelectric point determination and structure modeling of a single-chain Fv against HBsAg. Huanan Ligong Daxue Xuebao 2004; 31: 73-76
28. Masip L, Pan JL, Haldar S, Penner-Hahn JE, DeLisa MP, Georgiou G, Bardwell JC, Collet JF. An engineered pathway for the formation of protein disulfide bonds. Science 2004; 303: 1185-1189
29. Hoffmann F, Posten C, Rinas U. Kinetic model of in vivo folding and inclusion body formation in recombinant Escherichia coli. Biotechnol Bioeng 2001; 72: 315-322
30. Lamark T, Ingebrigtsen M, Bjornstad C, Melkko T, Mollnes TE, Nielsen EW. Expression of active human C1 inhibitor serpin domain in Escherichia coli. Protein Expr Purif 2001; 22: 349-358
31. Schwalbach G, Sibler AP, Choulier L, Deryckere F, Weiss E. Production of fluorescent single-chain antibody fragments in Escherichia coli. Protein Expr Purif 2000; 18: 121-132
32. Park SS, Ryu CJ, Kang YJ, Kashmiri SV, Hong HJ. Generation and characterization of a novel tetravalent bispecific antibody that binds to hepatitis B virus surface antigens. Mol Immunol 2000; 37: 1123-1130
33. Ramirez N, Ayala M, Lorenzo D, Palenzuela D, Herrera L, Doreste V, Perez M, Gavilond JV, Oramas P. Expression of a single-chain Fv antibody fragment specific for the hepatitis B surface antigen in transgenic tobacco plants. Transgenic Res 2002; 11: 61-64
34. Mayfield SP, Franklin SE, Lerner RA. Expression and assembly of a fully active antibody in algae. Proc Natl Acad Sci USA 2003; 100: 438-442
35. Ito M, Nagata K, Kato Y, Oda Y, Yamagoe S, Suzuki K, Tanokura M. Expression, oxidative refolding, and characterization of six-histidine-tagged recombinant human LECT2, a 16-kDa chemotactic protein with three disulfide bonds. Protein Expr Purif 2003; 27 272-278
36. Kurokawa Y, Yanagi H, Yura T. Overproduction of bacterial protein disulfide isomerase (DsbC) and its modulator (DsbD) markedly enhances periplasmic production of human nerve growth factor in Escherichia coli. J Biol Chem 2001; 276: 14393-14399
37. Jurado P, Ritz D, Beckwith J, de Lorenzo V, Fernandez LA. Production of functional single-chain Fv antibodies in the cytoplasm of Escherichia coli. J Mol Biol 2002; 320: 1-10